Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
January 8, 2026
/DISREGARD RELEASE: Arkbio/
January 6, 2026
Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD
January 6, 2026